Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI – Get Free Report) was up 10.2% during mid-day trading on Thursday after an insider bought additional shares in the company. The stock traded as high as $8.18 and last traded at $8.1550. Approximately 575,175 shares traded hands during mid-day trading, a decline of 36% from the average daily volume of 892,004 shares. The stock had previously closed at $7.40.
Specifically, Director Brett Brodnax bought 35,000 shares of the company’s stock in a transaction on Tuesday, May 19th. The stock was bought at an average cost of $7.25 per share, with a total value of $253,750.00. Following the completion of the purchase, the director owned 62,027 shares in the company, valued at approximately $449,695.75. The trade was a 129.50% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on the stock. Raymond James Financial raised shares of Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price target on the stock in a research note on Monday, February 9th. Barclays reduced their price objective on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating on the stock in a report on Wednesday. Finally, Weiss Ratings started coverage on Lumexa Imaging in a research note on Wednesday, May 13th. They issued a “sell (e-)” rating for the company. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $16.00.
Lumexa Imaging Stock Performance
The stock’s fifty day moving average is $9.87.
Hedge Funds Weigh In On Lumexa Imaging
Institutional investors and hedge funds have recently made changes to their positions in the company. Assetmark Inc. bought a new stake in shares of Lumexa Imaging in the 4th quarter valued at $36,000. Strs Ohio bought a new position in Lumexa Imaging during the first quarter worth about $38,000. PNC Financial Services Group Inc. acquired a new position in Lumexa Imaging in the first quarter valued at about $63,000. State of Wyoming bought a new stake in shares of Lumexa Imaging in the first quarter worth about $91,000. Finally, Barclays PLC acquired a new stake in shares of Lumexa Imaging during the fourth quarter worth about $133,000.
About Lumexa Imaging
We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).
Further Reading
- Five stocks we like better than Lumexa Imaging
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Lumexa Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumexa Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
